177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

Clinical trial NCT04915144 · WITHDRAWN

Trial details

NCT number: NCT04915144
Sponsor: British Columbia Cancer Agency
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors Carcinoid Tumor Pulmonary Carcinoid Tumor Gastroenteropancreatic Neuroendocrine Tumor Vipoma Insulinoma Gastrinoma

Start date: 2023-01-15
Primary completion: 2027-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.